Pharmacokinetic and Pharmacodynamic Study of a Novel Sublingual Aspirin Tablet

Summary

The objective of the study is to compare the pharmacokinetics and pharmacodynamics of a new sublingual formulation of aspirin with that of oral aspirin when administered to healthy volunteers under fasting conditions. The test product is sublingual aspirin 80 mg manufactured by Vita Green Health Products Co. Ltd, Hong Kong and the reference product is oral aspirin 80mg tablet manufactured by Synco (HK) Ltd, Hong Kong.

Timeline

Start

2021-03-05

Primary completion

2021-07-01

Completion

2021-09-01

Drugs

Indications